Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose after recent myocardial infarction in iron-deficient adults
2020-005740-27Phase 4Active
- Sponsor
- Wroclaw Medical University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in iron deficiency anemia (IDA) and myocardial infarction (MI) comparing Ferric carboxymaltose with Placebo (2 arms). Primary endpoint: Time to death from any cause. Started Jan 2021; status: active.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)myocardial infarction (MI)
Beyond the preview
Go deeper on 2020-005740-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005740-27.